INTERNATIONAL STEM CELL CORPORATION (ISCO) Total liabilities 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) total liabilities at each fiscal year-end, per SEC filings.
$4.6MFY2025 · since FY2016: $3.6M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.6M | -4.7% |
| FY2024 | $4.8M | -9.0% |
| FY2023 | $5.3M | -1.5% |
| FY2022 | $5.4M | +2.3% |
| FY2021 | $5.2M | -1.6% |
| FY2020 | $5.3M | +2.2% |
| FY2019 | $5.2M | -1.0% |
| FY2018 | $5.3M | +9.6% |
| FY2017 | $4.8M | +33.3% |
| FY2016 | $3.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ISCO financial trends
ISCO RevenueISCO Net incomeISCO Net marginISCO Gross profitISCO Gross marginISCO Operating incomeISCO Operating marginISCO Operating cash flowISCO Free cash flowISCO Capital expendituresISCO Return on equityISCO Stock buybacksISCO Dividends paidISCO Total assetsISCO Shareholders’ equityISCO overview →